244 related articles for article (PubMed ID: 23029393)
1. T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis.
Merlini E; Luzi K; Suardi E; Barassi A; Cerrone M; Martínez JS; Bai F; D'Eril GV; Monforte AD; Marchetti G
PLoS One; 2012; 7(9):e46073. PubMed ID: 23029393
[TBL] [Abstract][Full Text] [Related]
2. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.
D'Abramo A; Zingaropoli MA; Oliva A; D'Agostino C; Al Moghazi S; De Luca G; Iannetta M; Mastroianni CM; Vullo V
Mediators Inflamm; 2014; 2014():192594. PubMed ID: 25374442
[TBL] [Abstract][Full Text] [Related]
3. Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients.
Masiá M; Robledano C; Ortiz de la Tabla V; Antequera P; Lumbreras B; Hernández I; Gutiérrez F
PLoS One; 2014; 9(8):e105442. PubMed ID: 25133669
[TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+.
Marchetti G; Merlini E; Sinigaglia E; Iannotti N; Bai F; Savoldi A; Tincati C; Carpani G; Bini T; Arminio Monforte A
Curr HIV Res; 2012 Oct; 10(7):597-605. PubMed ID: 22716104
[TBL] [Abstract][Full Text] [Related]
5. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
Casado JL; Abad-Fernández M; Moreno S; Pérez-Elías MJ; Moreno A; Bernardino JI; Vallejo A
HIV Med; 2015 Apr; 16(4):240-8. PubMed ID: 25604328
[TBL] [Abstract][Full Text] [Related]
6. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.
Kaplan RC; Sinclair E; Landay AL; Lurain N; Sharrett AR; Gange SJ; Xue X; Hunt P; Karim R; Kern DM; Hodis HN; Deeks SG
J Infect Dis; 2011 Feb; 203(4):452-63. PubMed ID: 21220772
[TBL] [Abstract][Full Text] [Related]
7. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
[TBL] [Abstract][Full Text] [Related]
8. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression.
Serrano-Villar S; Gutiérrez C; Vallejo A; Hernández-Novoa B; Díaz L; Abad Fernández M; Madrid N; Dronda F; Zamora J; Muñoz-Fernández MÁ; Moreno S
J Infect; 2013 Jan; 66(1):57-66. PubMed ID: 23046968
[TBL] [Abstract][Full Text] [Related]
9. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
[TBL] [Abstract][Full Text] [Related]
10. T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors.
Bernal E; Martinez M; Torres A; Guillamón CF; Alcaraz A; Alcaraz MJ; Muñoz A; Valero S; Botella C; Campillo JA; Cano A; Minguela A
Antiviral Res; 2019 Feb; 162():163-170. PubMed ID: 30593833
[TBL] [Abstract][Full Text] [Related]
11. Subclinical atherosclerosis and immune activation in young HIV-infected patients with telomere shortening.
Alcaraz MJ; Alcaraz A; Teruel-Montoya R; Campillo JA; de la Torre A; Muñoz Á; Tomás C; Puche G; Báguena C; Cano A; Minguela A; Bernal E
Aging (Albany NY); 2021 Jul; 13(14):18094-18105. PubMed ID: 34310343
[TBL] [Abstract][Full Text] [Related]
12. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus-specific T-cells are associated with immune senescence, but not with systemic inflammation, in people living with HIV.
Ballegaard V; Brændstrup P; Pedersen KK; Kirkby N; Stryhn A; Ryder LP; Gerstoft J; Nielsen SD
Sci Rep; 2018 Feb; 8(1):3778. PubMed ID: 29491459
[TBL] [Abstract][Full Text] [Related]
14. Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.
Butterfield TR; Hanna DB; Kaplan RC; Kizer JR; Durkin HG; Young MA; Nowicki MJ; Tien PC; Golub ET; Floris-Moore MA; Titanji K; Fischl MA; Heath SL; Martinson J; Crowe SM; Palmer CS; Landay AL; Anzinger JJ
AIDS; 2017 Jan; 31(2):199-205. PubMed ID: 27835618
[TBL] [Abstract][Full Text] [Related]
15. T cell activation predicts carotid artery stiffness among HIV-infected women.
Kaplan RC; Sinclair E; Landay AL; Lurain N; Sharrett AR; Gange SJ; Xue X; Parrinello CM; Hunt P; Deeks SG; Hodis HN
Atherosclerosis; 2011 Jul; 217(1):207-13. PubMed ID: 21492857
[TBL] [Abstract][Full Text] [Related]
16. T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment.
Cobos Jiménez V; Wit FW; Joerink M; Maurer I; Harskamp AM; Schouten J; Prins M; van Leeuwen EM; Booiman T; Deeks SG; Reiss P; Kootstra NA;
J Infect Dis; 2016 Jul; 214(2):216-25. PubMed ID: 27073222
[TBL] [Abstract][Full Text] [Related]
17. Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy.
Jeong SJ; Kim CO; Song YG; Baek JH; Kim SB; Jin SJ; Ku NS; Han SH; Choi JY; Lee HC; Kim JM
Atherosclerosis; 2011 Dec; 219(2):778-83. PubMed ID: 21872861
[TBL] [Abstract][Full Text] [Related]
18. Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.
Shive CL; Freeman ML; Younes SA; Kowal CM; Canaday DH; Rodriguez B; Lederman MM; Anthony DD
Front Immunol; 2021; 12():638010. PubMed ID: 33868264
[No Abstract] [Full Text] [Related]
19. Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens.
Gonzalez-Serna A; Ferrando-Martinez S; Tarancon-Diez L; De Pablo-Bernal RS; Dominguez-Molina B; Jiménez JL; Muñoz-Fernández MÁ; Leal M; Ruiz-Mateos E
J Transl Med; 2017 Dec; 15(1):259. PubMed ID: 29262860
[TBL] [Abstract][Full Text] [Related]
20. Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patients.
Gazzola L; Bellistri GM; Tincati C; Ierardi V; Savoldi A; Del Sole A; Tagliabue L; d'Arminio Monforte A; Marchetti G
J Transl Med; 2013 Feb; 11():51. PubMed ID: 23448662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
